Antiandrogens inhibit the androgen receptor (AR) and play an important role in the treatment of prostate cancer (PC). This review provides a historical perspective on the development and clinical benefit of antiandrogens in the treatment of PC.
SAN DIEGO, CA USA (UroToday.com) - In this podcast, Dr. Michael Cookson discusses new treatment options for castration-resistant prostate cancer (CRPC).
SAN DIEGO, CA USA (UroToday.com) - Michael Cookson, MD, Vice Chair and Professor of Urologic Surgery at Vanderbilt, presented the first AUA guideline for the management of castration-resistant prostate cancer, a lethal form of the disease.
SAN DIEGO, CA USA (UroToday.com) - Presented by Michael S. Cookson, MD, MMHC* at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA
Login to update email address, newsletter preferences and use bookmarks.